Qiming Venture Partners and Founding Managing Partner Duane Kuang Named to 2024 List of World's Best Investment Institutions
The ranking reflects the influence of China's private equity market in the global investment industry.
Swipe Left for the English Version
At the inaugural China-Arab Investment Summit, the Global FOF Association released its List of the World's Best Investment Institutions in 2024. The list was compiled through recommendations, evaluations, and scoring by investment associations across Europe, the Americas, the Middle East, and other regions.
This year's selection included rankings for the TOP 50 Best Performing Funds, TOP 30 Best VC/PE Investors, and TOP 30 Best Exiting FOFs, among others. Qiming Venture Partners was named to the TOP 50 Best Performing Funds list, and Duane Kuang, Founding Managing Partner of Qiming Venture Partners, was recognized among the TOP 30 Best VC/PE Investors.
Qiming Venture Partners
Named to
TOP 50 Best Performing Funds
Duane Kuang, Founding Managing Partner of Qiming Venture Partners
Named to
TOP 30 Best VC/PE Investors
The Global FOF Association has released its annual list of the World's Best Investment Institutions for six consecutive years. In this year's rankings, Chinese investment institutions and investors accounted for over 30% of honorees — a reflection of China's private equity market's growing influence in the global investment industry.
The global private equity industry has entered a new cycle of development. Market systems are becoming more robust, participants more diverse, and mechanisms more sound, pointing to broad prospects ahead.
Source | China FOF Research Center
Qiming Venture Partners and Founding Managing Partner Duane Kuang Recognized in the List of the World's Best Investment Institutions in 2024
At the first China-Arab Investment Summit, the Global FOF Association released the List of the World's Best Investment Institutions in 2024. Qiming Venture Partners was named among the TOP 50 Best Performing Funds in the world, and our Founding Managing Partner, Duane Kuang, was recognized as one of the TOP 30 Best VC/PE Investors in the world.
The list was selected by the Global FOF Association through recommendations, evaluation, and scoring by investment associations in Europe, America, the Middle East, and other regions.
The Global FOF Association has released its annual list of the World's Best Investment Institutions for six consecutive years. Notably, over 30% of this year's honored institutions and investors are from China — underscoring the growing global influence of China's private equity and venture capital markets.
The global private equity investment industry has entered a new era, with the market becoming more complete, the participants more diverse, and the mechanisms more mature — indicating broad development prospects for the industry worldwide.
Source: china-fof.com
Past Highlights
Qiming Honors | Qiming Venture Partners and Founding Managing Partner Duane Kuang Win Five Awards at China FOF Research Center 2024 Annual Rankings Qiming Perspectives | Duane Kuang: AI Investment in China Is Not Overheated — It Should Attract Capital From Around the World Qiming Stars | Over 10 Qiming Venture Partners Portfolio Companies Named to 2024 High-Growth Tech Companies and Best CEO Rankings
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management of $9.5 billion. Since its inception, the firm has focused on investing in exceptional early- and growth-stage companies in the Technology and Consumer (T&C) and Healthcare sectors.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies. More than 210 of these have gone public on the New York Stock Exchange, Nasdaq, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or have exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many of Qiming Venture Partners' portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), Genrix Bio (688520.SH), Yuanxin Technology, ClinChoice, Belief BioMed, Biren Technology, and others.